🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Safety and Efficacy of ActiGraft Treatment in Wound Care in Medical Centers

Recruitingn/aAges 18 Years - anyAllRedDress Ltd.
NCT04699305 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Multicenter observational study to explore the efficacy of ActiGraft in the treatment of exuding cutaneous wounds in real-life usage.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Subject is ≥18 years of age * Subject has an exuding cutaneous wound * Subject agrees to the use of his health data, including photos of his wound in analysis and publications * Subject/LAR must be able to read and understand English and/or Spanish Exclusion Criteria: * Subject/LAR is unable to read and understand English or Spanish.
💊

What it tests

  • ActiGraft
📍

Where

1 site
Wound Care Experts
Las Vegas, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy